Printbio Introduces Dynaflextm Programmable Surgical Mesh (PSM) At American Hernia Society Meeting 2025
.DynaFlexTM Incorporates MetaDirectional FlexTM Technology to Create the First-of-Its-Kind Programmable Mesh
Our introduction of DynaFlexTM represents a new era in surgical repair. By giving surgeons programmable control over mesh mechanics, we are setting a new benchmark for innovation in hernia repair” - Dr. Kevin Slawin, Founder and CEO of PrintBio, and a former surgeonLONG ISLAND CITY, NY, UNITED STATES, September 4, 2025 /EINPresswire / -- PrintBio today announced commencement of its phased commercial rollout of DynaFlexTM Programmable Surgical Mesh (PSM) at the American Hernia Society Annual Meeting, being held September 4–6, 2025, in Nashville, TN.DynaFlexTM PSM is the first surgical mesh of its kind, designed to be infinitely customizable across multiple clinically relevant dimensions. Its proprietary MetaDirectional FlexTM technology enables the designer to create flexibility and stability in any vector, direction, or zone within the mesh- with potential to deliver personalized reinforcement for each patient.
Unlike category-standard knitted or woven meshes, DynaFlexTM PSM is free of cross-filament knots and weaves which may harbor bacteria. It also has generous interstitial spaces for new tissue growth while protecting those spaces from deformation under strain. By eliminating these structural limitations, DynaFlexTM is engineered to potentially limit contamination and optimize interstitial tissue integration while supporting tissue regeneration for long-term performance.
“Our introduction of DynaFlexTM represents a new era in surgical repair,” said Dr. Kevin Slawin, Founder and CEO of PrintBio, and a former oncologic surgeon.“By giving surgeons programmable control over mesh mechanics, we are addressing unmet clinical needs and setting a new benchmark for innovation in hernia repair.”
The initial phase of commercial rollout at AHS 2025 will include product demonstrations, educational discussions with key opinion leaders, and opportunities for surgeon engagement ahead of full commercialization.
For additional information please visit the PrintBio website at . To register additional interest, please fill out our Contact Form
Steve Pinto
PrintBio, Inc.
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Daytrading Publishes New Study On The Dangers Of AI Tools Used By Traders
- Primexbt Launches Empowering Traders To Succeed Campaign, Leading A New Era Of Trading
- Wallpaper Market Size, Industry Overview, Latest Insights And Forecast 2025-2033
- Excellion Finance Scales Market-Neutral Defi Strategies With Fordefi's MPC Wallet
- ROVR Releases Open Dataset To Power The Future Of Spatial AI, Robotics, And Autonomous Systems
- Ethereum-Based Meme Project Pepeto ($PEPETO) Surges Past $6.5M In Presale
Comments
No comment